LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Home・Akcijų sąrašas・VolitionRX Ltd

VolitionRX Ltd

Uždarymo kaina

0.2

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.2

Max

0.2

Pagrindiniai rodikliai
By Trading Economics
Pajamos	936K -5.4M
Pardavimai	221K 627K
Pelno marža	-857.414
Darbuotojai	75
EBITDA	1.3M -4.2M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+1025% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-03-30

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-16M 31M
Ankstesnė atidarymo kaina	0.2
Ankstesnė uždarymo kaina	0.2

VolitionRX Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-22 23:55; UTC

Rinkos pokalbiai

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

2026-02-22 23:53; UTC

Rinkos pokalbiai

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

2026-02-22 23:53; UTC

Rinkos pokalbiai

Key China Rates Likely to Be Held Steady for Now -- Market Talk

2026-02-22 23:51; UTC

Rinkos pokalbiai

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

2026-02-22 23:35; UTC

Rinkos pokalbiai

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

2026-02-22 23:21; UTC

Uždarbis

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

2026-02-22 23:20; UTC

Uždarbis

Nickel Industries 2025 Operating Profit US$126.4 Million

2026-02-22 23:19; UTC

Uždarbis

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

2026-02-22 23:19; UTC

Uždarbis

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

2026-02-22 23:18; UTC

Uždarbis

Nickel Industries Won't Pay a Final Dividend

2026-02-22 23:16; UTC

Uždarbis

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

2026-02-22 21:35; UTC

Uždarbis

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

2026-02-22 21:34; UTC

Uždarbis

Ampol Says F&I Australia, International Have Begun 2026 Strongly

2026-02-22 21:34; UTC

Uždarbis

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

2026-02-22 21:33; UTC

Uždarbis

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

2026-02-22 21:33; UTC

Uždarbis

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

2026-02-22 21:28; UTC

Uždarbis

Ampol Final Dividend A$0.60/Share

2026-02-22 21:28; UTC

Uždarbis

Ampol FY Revenue A$31.37 Billion, Down 10%

2026-02-22 21:28; UTC

Uždarbis

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

2026-02-22 21:28; UTC

Uždarbis

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

2026-02-21 14:31; UTC

Įsigijimai, susijungimai, perėmimai

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

2026-02-21 05:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-02-20 23:12; UTC

Įsigijimai, susijungimai, perėmimai

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

2026-02-20 22:12; UTC

Uždarbis

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

2026-02-20 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-20 21:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2026-02-20 21:23; UTC

Uždarbis

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

2026-02-20 21:20; UTC

Rinkos pokalbiai

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

2026-02-20 21:01; UTC

Įsigijimai, susijungimai, perėmimai

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

2026-02-20 20:38; UTC

Rinkos pokalbiai

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Akcijų palyginimas

Kainos pokytis

VolitionRX Ltd Prognozė

Kainos tikslas

By TipRanks

1025% į viršų

12 mėnesių prognozė

Vidutinis 2.25 USD 1025%

Aukščiausias 3 USD

Žemiausias 1.5 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines VolitionRX Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių VolitionRX Ltd akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.